Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone involved in regulating appetite and digestion
Refer to the MHRA for UK medicines regulation.
Common side effects include nausea, vomiting, diarrhea, stomach pain, decreased appetite, and fatigue
Price & Risk Comparison Table Which Option Makes the Most Sense
Clinical trials have shown this dose produces significant weight loss over 56 weeks, with many participants achieving 510 % of baseline body weight reduction
The ROS scavenging property of Sp was also replicated in the Drosophila models knocked-down for essential antioxidant enzymes catalase and glutathione peroxidase, where neuronal cells of 15 days AEL flies genetically expressing a redox biosensor, roGFP showed reduced fluorescence under Sp treatment (Fig